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Humaninducedpluripotentstemcells(hiPSCs)holdenormouspotential,howeverseveralobstaclesimpede
their translation to industrial and clinical applications. Here we describe a platform to efficiently generate,
characterize and maintain single cell and feeder-free (FF) cultured hiPSCs by means of a small molecule
cocktail media additive. Using this strategy we have developed an effective multiplex sorting and
high-throughput selection platform where individual clonal hiPSC lines are readily obtained from apool of
candidate clones, expanded and thoroughly characterized. By promoting survival and self-renewal, the
selectedhiPSCclonescanberapidlyexpandedovermultipleFF,single-cellpassageswhilemaintainingtheir
pluripotency and genomic stability as demonstrated by trilineage differentiation, karyotype and copy
numbervariationanalysis.Thisstudyprovidesarobustplatformthatincreasesefficiency,throughput,scale
and quality of hiPSC generation and facilitates the industrial and clinical use of iPSC technology.
H
uman induced pluripotent stem cells (hiPSCs) offer great promise for research and clinical applications
including the modeling of human disease, drug efficacy and safety screening and ultimately as a source of
autologous or allogeneic cells for regenerative medicine
1–8. iPSC generation was originally demonstrated
by the ectopic expression of defined transcription factors, namely Oct4, Sox2, Klf4 and cMyc
9. Although many
studies have further improved on this landmark innovation, hiPSC clone generation selection and characteriza-
tion has generally been low throughput: with few clones being identified, cultured and characterized on an
individual basis by the skilled stem cell biologist. It is clear that future applications of iPSC technology such as
genetic alteration for disease correction, loci-specific modulation for reporter systems or clone selection for
preferred differentiation potentialwillrequirehigherthroughput andmorereliablemethodsforclonederivation
andcharacterization.Oneofthehindrancestosuchtechnologyadvancementsarethattheculturesystemsusedto
date have followed those originally identified for conventional human embryonic stem cells (hESCs); i.e. clump
passaging, the use of a mouse embryonic fibroblast (MEF) feeder cell layer and non-defined media including
serum
10–16. Such systems are particularly laborious and inefficient for hiPSC generation and are not applicable to
defined and scalable culture for industrial or clinical use
17–19. In addition, reprogramming of somatic cells in a
feeder free (FF) culture system is an extremely inefficient process, adding a further obstacle to developing a
defined system for hiPSC generation
2. Recent studies have also demonstrated that hESCs and to a higher degree,
hiPSCs are susceptible to genomic abnormalities with some genomic changes occurring during the reprogram-
ming process and others occurring during extended passaging in culture
17,20–24. Therefore, before hiPSC techno-
logy can be effectively transitioned to industrial and clinical settings, challenges pertaining to the efficiency and
standardization of clone selection, characterization, scalability, and genomic stability must be addressed.
In the present study, we describe a multiplex cell sorting system to allow rapid selection, characterization and
expansionofhiPSCclonesinfeederfree(FF),singlecellpassageculturewhilemaintainingpluripotentstatusand
genomicstability.Keytothissystemistheidentificationofasmallmoleculecocktailofspecificsignalingpathway
inhibitors that can be used as a media additive to support and enhance the derivation of hiPSCs in a FF culture
environment. The use of this cocktail also results in hiPSCs with improved clonality and tolerance of single cell
passaging. Importantly, hiPSCs generated and maintained in FF and single cell culture using this unique small
molecule cocktail retain genomic stability as indicated by both karyotype analysis and copy number variation.
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gramming methods for the rapid and high-throughput derivation
and maintenance of industrial-grade hiPSCs.
Results
Defining cell culture additives to support high-throughput iPSC
generation,maintenanceandexpansion.Smallmoleculeinhibitors
of specific signaling pathways have been used in various aspects of
iPSC generation and maintenance. To determine whether a com-
bination of small molecules could be used to support FF culture
during somatic cell reprogramming and long-term single cell
culture, we investigated the inhibition of signaling pathways com-
monly associated with the perturbation of somaticcell reprogramm-
ing and pluripotent stem cell self-renewal and survival
16,25–37. With
an initial focus on expression of pluripotent markers such as Tra181
and the viability of cultured cells, our data demonstrated that the use
of various pathway inhibitors significantly influenced the survival
and maintenance of FF and single cell dissociated hiPSCs (Sup-
plementary Fig. 1). Significant cell death was seen when hiPSCs
previously generated on feeder cells were cultured on Matrigel
TM
using conventional medium and single cell enzymatic passaging
(Supplementary Figs. 1a–c). The addition of ROCK inhibition
enhanced cell viability and plating efficiency but resulted in
cellular differentiation whereas MEK, TGFb and GSK3 inhibition
enabled the maintenance of pluripotency but with significant cell
death (Supplementary Figs. 1a–c). However, combining the four
small molecules resulted in high viability and plating efficiency of
undifferentiated hiPSCs (Supplementary Figs. 1a–c). A recent high-
throughputchemicalscreenidentifiedThiazovivintobeaninhibitor
of ROCK activity and highly capable of promoting hESC survival
30.
In a direct comparison of Y27632 and Thiazovivin, it was seen
that while both inhibitors of ROCK promoted cell survival, the
combination including Thiazovivin better maintained the undif-
ferentiated state (Supplementary Figs. 1d,e). The final selected com-
bination and concentration of the small molecule media additives
was termed small molecule cocktail of 4 inhibitors (SMC4), con-
sisting of SB431542 (TGFbi), PD0325901 (MEKi), CHIR99021
(GSKi) and Thiazovivin (ROCKi) (Supplementary Table 1). This
combination also significantly augmented cellular reprogramming
in FF culture (Supplementary Fig. 1f). This single cell culture
system was therefore used as the basis for our subsequent studies
to define a high-throughput iPSC generation platform.
Adaptation of hiPSCs to FF and single cell passage culture using
SMC4-supplemented medium. Established, feeder-derived and
clump passaged hiPSCs were adapted to single cell culture on
Matrigel
TM-coated tissue culture plates using either conventional
medium or SMC4-supplemented medium (Fig. 1a). In contrast to
conventional culture, the SMC4 culture was able to support FF
hiPSC colony formation while preventing cell death (Fig. 1a and
Supplementary Fig. 2a). During subsequent FF culture in SMC4,
individual cells readily formed colonies and maintained their undif-
ferentiated status over multiple passages (Figs. 1b–e). Further, the
adapted cells displayed effective silencing of exogenous genes and
retainedtheirgenomicintegrity(Figs.1e,f).Interestingly,thehiPSCs
cultured in the SMC4-supplemented media grew as a homogeneous
monolayer on FF culture providing utility for future industrial
applications (Fig. 1b). To determine whether the single cell and FF
cultured hiPSCs were pluripotent, we removed SMC4 from culture
and allowed the hiPSCs to differentiate. When SMC4 was removed
fromculture,cellslosttheirundifferentiatedmorphologyandgained
a more differentiated flat and stretched appearance (Supplementary
Fig. 2b). After several weeks of differentiation, gene expression
profiles and markers representative of the three somatic lineages
were identified (Fig. 1g and Supplementary Fig. 2c). When intro-
duced into the renal capsule and testis of immune compromised
mice, SMC4 maintained hiPSCs gave rise to teratomas consisting
of the three germ layers (Fig. 1h). Collectively, SMC4 facilitated
hiPSCs adaptation to and maintenance in single cell dissociated
and FF culture.
Single cell sorting for the derivation of FF clonal hiPSCs. High-
throughput methods of hiPSC derivation and characterization
as well as clone or subclone derivation of existing or modified
hiPSCs will require single cell plating of prospective lines
38–40.
To test whether the SMC4 additive supported high clonality by
promoting enhanced seeding efficiency in FF culture, we flow-
cytometry sorted individual cells and monitored their progress.
SSEA4
1/Tra181
1 double positive hiPSCs were selected and plated
on FF surfaces and in SMC4-supplemented medium at various cell
densities, including 500 cells per well of a 6-well plate (52 cells per
cm
2). Within 24 hours of the sort, cell attachment and division was
seen and after 7 days SSEA4
1/Tra181
1 derived colonies were scored
for alkaline phosphotase (AP) expression (Figs. 2a–c). The sorted
cells were single cell cultured on FF surfaces for an additional 5
passages and shown to be a nearly homogenous population of
undifferentiated cells (Figs. 2d,e). To determine whether it was
possible to derive clonal or subclonal lines, hiPSCs were sorted
directly into FF 96-well plates containing SMC4. Various cell
densities of hiPSCs were seeded, including 1 cell per well (3 cells
per cm
2) with colony formation detected within 48 hrs (Supple-
mentary Fig. 3a). The individually sorted colonies readily expanded
in FF culture and were scored for AP expression on day 8, marking a
significant improvement over previously reported studies (Figs. 2f,g
and Supplementary Fig. 3b)
38,41. The addition of SMC4 to the me-
dium formulation resulted in the ability to use FF culture, single cell
passaging and produced hiPSCs with enhanced clonality; all char-
acteristics required for a high-throughput iPSC generation, screening
and maintenance platform.
Defining a high-throughput reprogramming platform. The ad-
vantages of the SMC4 culture were combined to develop a high-
throughput method for generating FF and clonally derived hiPSCs.
AschemewasdevisedtotreatinducedcellswithSMC4andselectfor
rare individual cells that have faithfully reprogrammed as indicated
by a combination of early and late pluripotency markers such as
SSEA4 and Tra181 (Fig. 3)
6,42. Selected cells would then be con-
tinually passaged in FF and single cell culture conditions in the
presence of SMC4 and thoroughly characterized (Fig. 3). As a
preliminary study, pluripotent cell enrichment was attempted using
magnetic beads. IMR90 fibroblast (IMR90) cells were used as the
starting cell since the generation of FF hiPSCs from this line has not
previously been obtainable
43. To initiate reprogramming, IMR90
cells were infected with individual lentiviruses expressing Oct4,
Klf4, Sox2 and cMyc (OKSM). Cells displaying SSEA4 were enriched
using magnetic bead-antibody conjugates on day 8 post infection
(‘‘Enrichment’’, Fig. 3 and Supplementary Fig. 4a). The enriched
cells were transferred to FF culture and supplemented with SMC4
or conventional reprogramming medium (Supplementary Fig. 4a).
Consistent with previous studies, very few SSEA4/Tra181 positive
colonies were observed in the presence of conventional medium
in combination with a FF system (Supplementary Figs. 4a,b)
43.I n
contrast, many SSEA4/Tra181 positive colonies were identified
when the enriched cells were transferred to FF culture with SMC4
medium (average of 55-fold increase, SMC4 vs. conventional;
Supplementary Fig. 4b). The hiPSC lines derived using SMC4
comprised a nearly homogeneous population of undifferentiated
cells and expressed markers of pluripotency, displayed attenuation of
exogenous gene activity and differentiated into cell types representing
all three somatic cell lineages (Supplementary Figs. 4b–f). A similar
strategy was also taken for the FF derivation of hiPSCs from adipose
stem cells (Supplementary Figs. 5a–d). To further improve FF
reprogramming efficiencies, we constructed 3-factor (Oct4, Klf4 and
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 213 | DOI: 10.1038/srep00213 2Figure 1 | Single-cell and FF culture of adapted hiPSCs in SMC4. (a) hiPSCs previously generated on feeder cells with conventional medium were
passaged onto FF culture and maintained as single cell culture with either conventional medium or conventional medium supplemented with SMC4
(adaptedhiPSCclone termed, FateTherapeuticshiPSCclone (FTi)60).Lower-leftpanel represents markerexpression ofgenerated hiPSCclone prior to
adaptation. (b) Five day time course of single cell dissociated and FF cultured hiPSCs in SMC4 growing into colonies and subsequent confluent culture.
(c) SSEA4 and Tra181 profiles of continuously passaged adapted FTi60 in FF and single cell culture. Profiles represent passages 2, 6 and 10, respectively.
(d)FTi60 maintained inSMC4culture for10passages were stainedfor DAPI(blue),Nanog (green) andTra160(red).(e)qRT-PCRforendogenous and
exogenous gene expression of pluripotent markers was conducted on the original IMR90 cells (Fibroblasts), IMR90 cells infected by reprogramming
factor for 4 days post infection (Day 4 P.I.), human ESCs (H1 and HUES9) and FF maintained hiPSCs in SMC4 (FTi60). Expression was normalized to
Gapdh and relative within each gene group analyzed. Error bars represent standard deviation. (f) Cytogenetic analysis on 20 G-banded metaphase cells
derived from passage 11 FTi60 maintained in FF culture and supplemented with SMC4. (g) FTi60 maintained in FF culture and SMC4 was induced to
differentiate for 21 days and stained for markers of various lineages including: Mesoderm, alpha smooth muscle actin (aSMA); Ectoderm, Tuj1;
Endoderm, Sox17.(h) Histological sections of teratoma derived from FTi60 maintained in FF culture and SMC4. Black arrows point to areas of interest:
Mesoderm, smooth muscle; Ectoderm, neural rosettes; Endoderm, glands.
www.nature.com/scientificreports
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polycistronic-OKSM) polycistronic lentiviral vectors. These vector
systems were tested in combination with the SMC4 culture system
and cell selection method (Supplementary Figs. 6a,b). When we
compared fibroblast reprogramming in the SMC4, FF system it
was seen that the polycistronic lentiviral systems significantly
improved the efficiency of colony formation over the same repro-
gramming factors in individual viral constructs (Supplementary
Table 2). Further, the use of polycistronic vector systems and the
SMC4 culture system enabled an approximate 25-fold improvement
in reprogramming efficiency when compared to previously reported
feeder-free and individual reprogramming systems (Supplementary
Table 2)
43,44.
We next attempted to derive hiPSCs by directly selecting indi-
vidual reprogrammed cells through cell sorting using a combina-
tion of markers at an early stage in the reprogramming process
(‘‘Selection’’, Fig. 3). In a demonstration of the pharmaceutical
approach for hiPSC generation, we obtained patient consented fore-
skin derived fibroblast cells and induced them to reprogram with
polycistronic-OKSM lentivirus. Eight days after sorting and 20 days
after the original initiation of reprogramming, hiPSC colonies were
readily identified and picked (Supplementary Fig. 7a). After 10 pas-
sagesinFFandsinglecellculturewithSMC4,theindividualcolonies,
Fate Therapeutics hiPSC clones (FTi) 70 and 72, were seen to have
maintained their undifferentiated status, retained genomic stability
and were able to give rise to all three germ layers (Supplementary
Figure 2 | Highly efficient single cell sorting of FF hiPSCs. Single cells dissociated hiPSCs (FTi60) were flow-cytometry sorted for SSEA4/Tra181 dual
expression and plated at various densities on FF surface coated with Matrigel and SMC4 supplemented medium. (a) Twenty-four hours post sorting,
seededcells havebeguntodivide andatday7large colonies consisting ofmany cellswere readilyobserved. (b), (c)hiPSCcolonies ateach seeded density
werestainedforAPexpressionandscored7dayspostsort.N.C.:notcountedduetoconfluencypreventingaccuratecounts.(d),(e)After5passagespost
sort, approximately 1 month in culture, sorted FTi60 culture was stained for Tra160 (Red) and DAPI (Blue, lower right hand panel) and assessed for
SSEA4 and Tra181 coexpression by flow-cytometry. (f) SSEA4
1/Tra181
1 cells of generated hiPSC clone FTi93 were sorted directly into 96 well-plates at
various densities. Representative images of wells stained for AP expression 8 days post sort. (g) Wells of the sorted 96-well plates were scored for
containingAPcoloniesonday8.Analysisofeachdensitywasconductedintriplicate96-wellplates.Errorbarsrepresentstandarddeviationoftriplicates.
www.nature.com/scientificreports
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double positive cells effectively leads to the derivation of hiPSCs,
reprogramming was reinitiated using the polycistronic-OKSM len-
tivirus but with individual cells directly sorted into wells of a FF 96-
wellplateat1and3cellsperwell(SupplementaryFig.7e).Usingthis
platform, FF hiPSC clonal lines were derived in 96-well plates and
assessed for their undifferentiated status by flow-cytometry (Supple-
mentary Fig. 7f). On further analysis some of the clones derived in
this manner contained non-clonal aberrations, suggestive of geno-
mic instability (Supplementary Fig. 7g).
To avoid the potential selection of any non-clonal aberrations
during long-term culture, we decided to repeat individual cell selec-
tion using the polycistronic-OKS lentivirus reprogramming system
as it has been shown that reprogramming without cMyc improves
genomic stability
45. Furthermore, we coupled the reprogramming
process with a multiplex platform to effectively select for the top tier
clones based on selection assays of flow-cytometry, qRTPCR and
immunofluorescence (Fig. 4). In an optimized multiplex protocol,
reprogrammingwasinitiatedusingthepolycistronic-OKSlentivirus,
an initial bulk sort of the SSEA4
1/Tra181
1 population was com-
pleted on day 20 post infection followed by resorting into 96 well-
plates on day 30 (Fig. 4). In this way 50 individual clones were
selected, replicate plated and characterized. Clones seen to maintain
SSEA4
1/Tra181
1 double positive status by flow cytometry, express
NanogandattenuateexpressionoftransgenebyqRTPCRandscored
positive for Oct4 and Nanog expression by immunofluorescence
were chosen for expansion and further characterization (Fig. 4).
Three independent patient consented fibroblast cell lines (FTC1, 5
and 7) were reprogrammed using the high-throughput multiplex
methodology (Fig. 4). After this initial selection using multiplex
methods of scoring pluripotency, selected clones were expanded
and further characterized (Fig. 4). As seen in figure 5, FTC1 derived
hiPSC clones (FTC1 clones 1 and 2) were further characterized to
exhibit expression of pluripotency markers, attenuation of exo-
genous gene activity and de-methylation of the Oct4 promoter
(Figs. 5a–c). These clones were also shown to be pluripotent by
differentiating into the three somatic lineages by both in vitro differ-
entiationandteratomaformation(Figs.5d,e).Uponfurtheranalysis,
global gene expression of SMC4 generated and cultured hiPSCs
demonstrated similar gene expression of core markers of pluripo-
tency but with further silencing of differentiated genes when com-
pared to conventionally cultured hESC H1 and hESC HUES9 and
conventionally generated and cultured hiPSCs (FTi99) from the
same starting fibroblast line (Fig. 5f and Supplementary Fig. 8).
High-throughput platform generated hiPSC clones from FTC5 and
7 were also thoroughly characterized and shown to express markers
of pluripotency, as well to give rise to all three germ layers in vitro
(Supplementary Figs. 9a,b). All selected clones were assessed for
chromosomal integrity by karyotype analysis after 20 continuous
single cell passages in FF and SMC4 culture: a normal karyotype
was seen for both FTC1 derived clones, all four FTC5 clones and
two of the four FTC7 derived clones (Fig. 6a and Supplementary Fig.
9c). Although the results suggest that the majority of derived and
long-term cultured hiPSCs have maintained their genomic stability,
the low frequency of acquired genomic aberrations highlights the
requirement for thorough characterization of all derived and main-
tained hiPSC lines. To assess genomic stability at higher resolution,
FTC1 clones 1 and 2 were analyzed by comparative genomic hybrid-
ization using NimbleGen 135 K array platform where copy number
variation (CNV) is determined by competitive differential hybrid-
ization of 135,000 labeled probes to the genomic DNA. FTC1 clones
1and2demonstratedminimal CNVwithonly12and13testsample
CNVs,respectively (Fig.6b).This comparesfavorably withthe start-
ingfibroblastlinewhichhad14testsampleCNVs(Fig.6b).Thus,the
combination of polycistronic-OKS lentivirus induction, SMC4-sup-
plemented medium and a multiplex characterization platform sig-
nificantlyenhancesthekineticsofFFreprogrammingwhileenabling
the identification, selection and expansion of clonally derived and
genomically stable hiPSCs in a high-throughput manner.
Discussion
Realizing the potential of hiPSCs for disease modeling, drug screen-
ing and ultimately disease correction and cell therapy will require
several advancements in the underlying technology. Much progress
has been made in advancing reprogramming technology towards
potentially safer methods
10,12,46,47. However, standardized methods
for high throughput hiPSC generation, characterization and clo-
nal expansion in culture environments applicable to industrial and
Figure 3 | EnhancedFFreprogrammingstrategy. AschematicdepictionofsortingmethodologiesfortheenrichmentandtheselectionofhiPSCsfroma
mix population. After the initiation of reprogramming and treatment with SMC4, the mixed population is sorted for established hiPSCs that express
multiple markers of pluripotency including SSEA4 and Tra181 (solid line, termed Selection). Selected cells are individually sorted, for example into 96-
wellplates.Inahigh-throughputmanner,clonalhiPSCarethenselected,characterizedandexpanded.Inanalternativestrategy,themixedpopulationof
reprogramming cells that have begun to express early pluripotent markers such as SSEA4 are enriched and maintained in SMC4 (dotted line, termed
Enrichment). Identified hiPSC colonies are picked, characterized and expanded. In either case, the selected hiPSC lines are maintained on FF culture in
SMC4 supplemented medium and expanded as clonal populations in long-term culture during routine single cell culture.
www.nature.com/scientificreports
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Further, the maintenance or selection for pluripotent quality and
genomic stability will be a requirement for all downstream applica-
tions.Tothisend,weaimedtodefineasimplemultiplexapproachto
iPSC generation and characterization that would yield high quality
and genomically stable hiPSC clones. Our initial strategy to define
cultureconditionsthatwouldallowFFcultureandsinglecellpassage
of hiPSCs resulted in the identification of a unique combination and
concentration of small molecules, SMC4 (Supplementary Table 1).
The addition of this cocktail of small molecules to conventional
medium facilitates enhanced FF reprogramming, in part by allowing
the selection of hiPSCs from the reprogramming cell milieu using
surface markers. Both hiPSC enrichment on magnetic beads and
selection by flow-cytometry sorting was demonstrated, allowing
identification and selection of rare and unique reprogramming
events in addition to generating multiple iPSC lines from any given
Figure 4 | High-throughput FF reprogramming platform. Polycistronic-OKS lentivirus induced fibroblast cells are sorted in a two step fashion to
deliveranefficient96-wellplatingplatformusingSMC4supplementedmedium.Fiftywellscontainingindividualcoloniesaremarkedandexpandedinto
4x96-well plates to attain a total of 50 individual clones for analysis. One set is designated as the master-plate and expanded, the other three plates are
processed for characterization including flow-cytometry analysis for surface marker expression including SSEA4 andTra181, qRTPCR forexpressiono f
key markers including Nanog and transgene silencing and immunofluorescence for pluripotent markers including Oct4 and Nanog. The data panels
representsnapshotsoftheclonessurveyed(markedbywells31–40ofthe96-wellplate)during thehigh-throughput platformhiPSCgenerationofFTC5.
In the qPCR panel, expression was normalized to Gapdh. Nanog expression is relative to H1 hESC while transgene expression is relative to day 4 post
infection of FTC5 (Day 4 infection). Based on the characterization readouts, selected hiPSC clones are expanded for further analysis and banked. In the
highlighted example, well 37 was identified as a candidate for expansion based on its multi-parameter pluripotency profile and termed FTC5 clone 1.
Immuno-fluorescence images were taken at 5x magnification.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 213 | DOI: 10.1038/srep00213 6Figure 5 | High-throughputplatform,clonalandFFderivationof3-factor(polycistronic-OKS)hiPSCsinthepresenceofSMC4. (a)FTC1clones1and
2werestainedforexpressionofpluripotentmarkers.(b)qRT-PCRofendogenousgeneexpressionofpluripotentmarkersforforeskinfibroblast(FTC1),
hESClines(H1andHues9),FTC1derived hiPSCclones(FTC1clones 1and2)andday4postinfectionofFTC1(Day4P.I.).Expressionwasnormalized
to Gapdh and relative within each gene group. Error bars represent standard deviation of replicates. (c) Oct4 promoter methylation status. Open circles
represent unmethylated CpG islands while dark circles represent methylated CpG islands. (d) EB formation and differentiation of clones FTC1 clones 1
and 2 each at passage 10; 28 days post differentiation: Endoderm, FoxA2; Mesoderm, alpha smooth muscle actin (aSMA); Ectoderm, Tuj1.
(e) Histological sections of teratoma derived from FTC1 clone 2 passage 18, generated and maintained in FF culture and SMC4. Black arrows point to
areas of interest: Mesoderm, white adipose tissue; Ectoderm, neurons; Endoderm, glands. (f) Relative gene expression based on Affymetrix gene
expression analysis of selected genes associated with pluripotency and lineage differentiation compared between SMC4 group (FTC1 clones 1 and 2)
versus conventional culture group (H1, Hues9 and FTi99).
www.nature.com/scientificreports
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systems where reprogramming efficiencies are significantly lower.
Moreover, the increased cell viability imparted by SMC4 enabled
routineselectionofindividualhiPSCsbysortingdirectlyinto96-well
cellcultureplates,resultinginthedevelopmentofahigh-throughput
platform (Figs.3,4). We established amultiplexmethod of simultan-
eous cell characterization and master-plate expansion and storage.
This technique vastly reduces time and researcher effort in the gen-
eration of multiple iPSC lines. By using this approach a researcher is
abletogenerate,characterizeandsurveymultipleclonesorsubclones
from multiple reprogramming experiments in parallel. Importantly,
the hiPSC clones generated in this way were fully characterized and
seen to maintain pluripotency and genomic stability. In contrast to
recent studies
22, high resolution comparative genomic hybridization
analysis of our hiPSCs shows genomic stability, with minimal copy
number variations in comparison to the starting fibroblast line even
after multiple subsequent FF, single cell passages. As recent studies
have continued to improve reprogramming methods by introducing
safer and more efficient induction strategies
48,49, our current plat-
form has the potential to make all reprogramming strategies high-
throughput, while making the reprogramming process independent
of feeder cells and amenable to single cell culture. This platform
is also seen to improve the efficiencies of the less effective methods
for generating of hiPSCs, such as FF 3-factor reprogramming
Figure 6 | Genomicstability ofFFandsinglecellculturedhiPSCsinthepresenceofSMC4. (a)Karyotypesummarytableofhigh-throughput platform
FTC1,5and7hiPSCderivedclones.AllhiPSCclonesweremaintainedinFFandsinglecellcultureinthepresenceofSMC4fortheindicatedpassageprior
to analysis. (b) Copy number variation as assessed by array comparative genomic hybridization. Bottom table is an interpretation summary of the data.
p, passage number.
www.nature.com/scientificreports
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appear to be more genomically stable than 4-factor OKSM derived
hiPSCs, supporting previous findings that oncogene cMyc dysregu-
lates cell cycle checkpoints and chromosomal stability
45. It also
appears that by effectively supporting hiPSCs in FF and single cell
culture,thereislessselectionpressureforclonaloutgrowthofhiPSCs
that have gained an advantage through undesirable chromosomal
alterations.BeyondhiPSCgenerationthishigh-throughputplatform
system can be applied to strategies such as disease correction, where
survey through large number of lines may be required. It has also
been shown that various iPSC clones have different propensities to
differentiate, this high-throughput platform could be used to select
clones with the highest potential for cell type specific differentiation.
Therearenowmanytechniquesandmethodsforthederivationof
pluripotentcellsviatheinvitroreprogrammingofsomaticcells.This
hasledtobothanexpansionofthefieldandarequirementforcareful
characterization and comparison of the resulting cells. Several plur-
ipotency states may also exist adding to the complexity of analysis
50.
Going forward there will be a greater demand for uniformity of
procedures and production for hiPSCs. SMC4 serves as a unique
small molecule cocktail that alleviates the need for feeder cells, aids
the reprogramming process and supports single cell culture for both
long-term maintenance and processes such as flow-cytometry sort-
ing. Furthermore, FF hiPSCs cultured in SMC4 are ideal for high-
throughput screening asthe cultured cells aremonolayer and homo-
geneous. These properties combined with the high-throughput,
multiplex method for hiPSC generation and subsequent character-
ization contribute to an ‘‘all in one’’ technique amenable to various
pluripotent cell research and industrial applications.
Methods
Cell Culture of Pluripotent Stem Cells. Prior to FF adaptation, conventionally
culturedhiPSCswereroutinelymaintainedonfeedercells,mitomycinCtreatedMEF
cells (Millipore), and cultured with conventional hESC medium (referred to as
conventional medium in the text) containing DMEM/F12 (Mediatech), 20% v/v
knockout serum replacement (Invitrogen), 1% v/v non-essential amino acids
(Mediatech), 2 mM L-glutamine (Mediatech), 100 mM b-mercaptoethanol
(Invitrogen) and 10 ng/mL bFGF (Invitrogen). Upon confluency, conventionally
cultured hiPSCs were enzymatically dissociated using 1 mg/mL collagenase IV
(Invitrogen) for 7 min at 37uC followed by mechanical dissociation into small pieces
(termed as clump passaging), collected and dilute passaged 1:3–1:4 onto freshly
seeded mitomycin C treated MEF cells every 5–7 days with daily addition of hESC
medium. Cellculturesweremaintainedin a humidified incubator set at 37uCa n d5 %
CO2. For adaptation to FF and single cell culture, upon confluency conventionally
cultured hiPSCs were clump dissociated and resuspended in MEF cell conditioned
medium(hESCmediumconditionedonMEFcellsfor24 hrsandsupplementedwith
10 ng/mL bFGF prior to use) and transferred to FF tissue culture plates (BD
Biosciences) that were previously coated with Matrigel
TM (1525 dilution; BD
Biosciences)for1–2 hrsin37uC.MEFconditionedmediumwaschangeddaily.Upon
confluency of greater than 90%, conditioned medium was switched to SMC4
supplemented medium [Supplementary Table 1, hESC medium supplemented with
0.4 mM PD0325901 (Biovision), 1 mM CHIR99021 (Biovision), 5 mM Thiazovivin
(internally synthesized at Fate Therapeutics Inc. and purchased from Biovision) and
2 mM SB431542 (Biovision)] two hours prior to single cell dissociation, see below.
Smallmoleculesweremaintainedin220uCpriortotheadditiontomediumatastock
concentrationof5–25 mMinDMSO.All working mediaweremaintainedin4uCfor
the duration of usage. In studies that included Y27632 (Ascent), 10 mM was used.
For single cell dissociation, hiPSCs were washed once with phosphate buffered
saline (PBS) (Mediatech) and treated with Accutase (Millipore) for 3–5 min at 37uC
followed with pipetting to ensure single cell dissociation. The single cell suspension
was then mixed in equal volume with conventional medium, centrifuged at 250 g for
5 min and resuspened in SMC4 supplemented medium (Supplementary Table S1).
After resuspension in SMC4 supplemented medium, the single cells were
transferredtoFFtissuecultureplatesthatwerepreviouslycoatedwithMatrigel
TMfor
1–2 hrsin37uC.Inthisformat,cellsroutinelyreceivedfreshmediumeveryotherday
andwerepassagedwhenconfluencyhadreach65–75%,whichnormallyoccurred4–5
days post passage. With each passage cells were re-dissociated into single cells and
transferred to a new tissue culture plate coated with Matrigel
TM at a dilution passage
of 1:8–1:15.
Induction of Reprogramming. To initiate the reprogramming process, ectopic
expression of reprogramming factors were induced by lentiviral transduction. Most
typically OKSM or OKS were used as indicated per each study. In most cases, the
starting cells were plated at 10% confluency (i.e. 1x10
5 cells per well of a 6-well plate)
on gelatin (Mediatech) coated surface. For the method of viral infection, freshly
collected lentivirus was added to the starting cells at a dilution of 152, supplemented
with 4 mg/mL polybrene (Millipore), and transferred to 37uC and 5% CO2 for
8–12 hrs. After the completion of the incubation, the cells were washed three times
with PBS and fed with fibroblast medium: DMEM (Mediatech), 10% FBS
(Invitrogen), 1x glutamax (Invitrogen), 1x non-essential amino acids (Mediatech).
Upon confluency (usually between days 4–6) the cells were dissociated with trypsin
(Invitrogen), mixed with equal part fibroblast medium, centrifuged at 250 g for
5 min,resuspended inSMC4supplementedmediumandexpanded1:10intoalarger
culture plate. Cultures are maintained in SMC4 until the next application.
Unique Population Enrichment. Approximately 8–12 days after the induction of
reprogramming,cells were dissociated into single cells with Accutase (Millipore) and
stainedwithvarioussurfacemarkersofpluripotency,markersofsomaticcellsand/or
markersofincomplete reprogramming.Briefly, dissociated cellswereresuspended in
staining solution containing Hanks’ Balanced Salt Solution (Invitrogen), 4% fetal
bovine serum (Invitrogen) and 10 mM Hepes (Invitrogen) and kept on ice. Per
recommendedmanufacturers’dilution,conjugatedprimaryantibodieswereaddedto
the cell solution and incubated on ice for 15 min. The cell solution was washed and
resuspended in staining buffer and maintained on ice. At this point various
enrichment/depletion strategies were taken; including Fluorescent Activated Cell
Sorting (BD Biosciences, see below) and Magnetic Cell Sorting (Miltenyi Biotec, see
below).
FlowcytometrysortingwasperformedonFACSAriaII(BDBiosciences).Primary
antibodiesusedincludeSSEA4-AlexaFluor-488/555(BDBiosciences),Tra181-Alexa
Fluor-488/647(BDBiosciences),Tra161-Alexa Fluor-488/647(BDBiosciences).The
cells were collected in SMC4 supplemented medium. The sorted cells were then
centrifuged and resuspended in SMC4 supplemented medium and transferred
to Matrigel
TM coated tissue culture plates. For additional improvement in seeding,
5 mg/mL Fibronectin (BD Biosciences) can be added to SMC4 for the first two days.
When sorted into microwells, i.e. 96 well plates, each well is prefilled with SMC4 and
upon completion of the sort the plates were centrifuged for 2 min at 300 g prior to
incubation.TheSMC4supplementedmediumwasreplacedeveryotherdayexceptin
case of 96-well plate sorting where it was replaced after 3–4 days in culture. Colony
formation was typically seen 2–4 days post sort. Flow cytometry analysis was
performed on Guava EasyCyte 8 HT (Millipore).
MACS Microbeads (Miltenyi Biotec) separation was performed according to
protocol. Briefly, cells were dissociated into single cells and stained with appropriate
FITC-conjugated primary antibodies, including SSEA4-FITC (BD Biosciences) and
Tra181-FITC (BDBiosciences).Cellswerethenmagneticallylabeled withAnti-FITC
Microbeads (Miltenyi Biotec). The labeled cell suspension was then loaded onto a LS
MACS Column (Miltenyi Biotec). The collected cells from either positively or
negatively selected fractions were centrifuged at 250 g for 5 min and resuspended in
SMC4supplementedmediumandtransferredtoMatrigel
TM(BDBiosciences)coated
tissue culture plates. The following day, fresh medium is added to the culture and
subsequently replaced every other day. The appearance of colonies is typically seen
2–4 days post sort.
Isolation and culture of patient consented human neonatal foreskin fibroblast
cells. Protocol and donor consent form were approved by the independent
Institutional Review Board of Chesapeake Research Review (Columbia, MD). The
parents of 2-day old baby boy provided their written informed consent for the use of
their son’s foreskin biopsy for the generation of iPSCs. The tissue was collected in
Hanks’balancedsaltsolution(HBSS),cutintosmallpieces(3–4 mm),andincubated
with dispase (BD Biosciences) overnight at 4uC. The dermis was separated from the
epidermis and cut further into 0.5 mm-pieces and 10 to 15 pieces placed in 100-mm
dish. Autoclaved cover-slips werelaid on topof the dermalpieces toholdthem down
and 6 ml of fibroblast media slowly added to the edge of the dish. Fresh medium was
added every 3–4 days and floating tissue pieces were removed. After two weeks, cells
werereadytocollectusing trypsin.Additional patientconsented fibroblast lines were
obtained from ZenBio Inc.
Alkaline Phosphatase Staining. Cells were fixed in 4% v/v paraformaldehyde (Alfa
Aesar), washed three times with PBS and stained with Alkaline Phosphatase Staining
Kit (Sigma-Aldrich). Briefly, 1 mL Sodium Nitrite Solution was added to1 mL FRV-
Alkaline Solution, mixed and incubated at 25uC for 2 min. The solution was then
mixedwith45 mLofH2Ofollowedbytheadditionof1 mLNaphtholAS-BIAlkaline
Solution.Thealkaline-dyemixturewasaddedtothefixedcellsandincubatedat25uC
for 15 min followed by a PBS wash. The cells were then scored for the presence of
alkaline phosphatase.
Immunofluorescence Staining. Cells were fixed using 4% v/v paraformaldehyde
(AlfaAesar),washedthreetimeswithPBScontaining0.2%v/vTween(PBST)(Fisher
Scientific) and permeablized using 0.15% v/v TritonX-100 (Sigma-Aldrich) in PBS
for 1 hr at 25uC. After permeabilization, cells were blocked with 1% v/v BSA
(Invitrogen) in PBST (PBSTB) (Fisher Scientific) for 30 min at 25uC. After gentle
removalofPBSTB,cellswereincubatedwithprimaryantibodyinPBSTBovernightat
4uC. Primary antibodies used in this study include Nanog (Abcam), Tra160 (BD
Biosciences),Tra181(BDBiosciences),SSEA4(BDBiosciences),b-IIITubulin(R&D
Systems), a-Smooth Muscle Actin (Sigma), FoxA2 (R&D Systems) and Sox17 (R&D
Systems). After the overnight incubation, cells were washed three times with PBST
and stained with secondary antibody (Alexa 488 or 555; Invitrogen) diluted 1:500 in
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 213 | DOI: 10.1038/srep00213 9PBSTB for 1 hr at 25uC. The cells were washed three times in PBST and stained with
Hoechst dye (Invitrogen). Images of the stained cells were captured using the Zeiss
fluorescence microscope and CCD camera.
Induction of Differentiation. hiPSC were differentiated as EBs or monolayers in
differentiationmediumcontainingDMEM/F12(Mediatech),20%fetalbovineserum
(Invitrogen), 1% non-essential amino acids (Mediatech), 2 mM L-glutamine
(Mediatech) and 100 mM b-mercaptoethanol. Briefly, for EB formation hiPSCs were
single cell dissociated with Accutase (Millipore) and resuspended in differentiation
medium to a final concentration of 75,000 cells/mL and 5 uM Thiazovivin was
added.Cellswereseededin100 mL/wellinV-bottom96-wellnon-tissue cultureplate
(Nunc) and centrifuged at 950 g for 5 min. The following day compact ‘‘ball-like
clumps’’ were transfer to ultra-low binding 6-well plate (Corning) using P1000 at
approximately 30–40 EBs/well. After 7 days, EBs were transferred at 1:1 to Matrigel
coated 6-well plate. After 3 weeks in culture, cells were fixed and stained. For
monolayer differentiation, hiPSCs were seeded in SMC4 and switched to
differentiation medium the next day. Once the medium had been switched, the
hiPSCs were allowed to differentiate for 14–21 days. Medium was changed every
2–3 days.
RT-qPCR Analysis. RNA was isolated using the PicoPure RNA Isolation kit (Life
Technologies), and 0.5 mg RNA was used to generate first strand cDNA using the
iScript cDNA Synthesis Kit (Bio-Rad). Relative gene expression levels were
determined usingthe TaqMan FastUniversal PCRMaster Mix(Applied Biosystems)
and the FAM-labeled TaqMan probes listed in Supplementary Table 3.
Gene Expression Analysis. Total RNA was isolated from cells using Pico Pure RNA
Isolation Kit (Life Technologies). In brief, biotinylated aRNA was prepared using the
standard protocol for MessageAmp II aRNA Amplification Kit (Applied
Biosystems/Ambion,Austin, TX) utilizing the optional Second Round Amplification
and then transcribed into biotin labeled aRNA using MessageAmp II Biotin
Enhanced Kit (Applied Biosystems/Ambion, Austin, TX) using the standard
protocol. Biotin labeled aRNA was purified and fragmented according to Affymetrix
recommendations. 20 mg of fragmented aRNA were used to hybridize to the Human
Genome U133 Plus 2.0 chips (Affymetrix Inc. Santa Clara, CA) for 16 hrs at 45uC.
The arrays were washed and stained in the Affymetrix Fluidics Station 450 and
scanned using the Affymetrix GeneChip Scanner 3000 7G. The image data were
analyzed using Affymetrix Expression Console software using default analysis
settings. Arrays were normalized by log scale robust multi-array analysis (RMA) and
visualized in Spotfire for Genomics 3.1 (Tibco Spotfire, Palo Alto, CA).
Karyotype Analysis. Cytogenetic analysis was performed on twenty G-banded
metaphase cells by Cell Line Genetics (Madison, WI) or WiCell (Madison, WI).
Comparative Genomic Hybridization. High resolution comparative genomic
hybridization (NimbleGen 12x135 k array; HG18 WG CGH v3.1 HX12) and
subsequentcopynumbervariationanalysiswasconductedbyWiCell(Madison,WI).
Briefly,relativecopynumberisdetermined bycomparativedifferentialhybridization
of labeled genomic DNA to the 135,000 oligonucleotide whole genome tiling array.
Statistical Analysis. Student’s t test was used for statistical evaluations pertaining to
standarddeviation.StepOneSoftwarev2.2(LifeTechnologies)wasusedtodetermine
RQ minimum and maximum values (error bars).
Teratoma Formation. Teratoma grafting and analyses was conducted by Applied
Stem Cells (Menlo Park, CA). Briefly, 1–5 million single cell dissociated hiPSCs were
mixed in 100 uL SMC4 supplemented medium and 100 uL Matrigel and introduced
to the renal capsule and testis of Beige SCID mice. The developed teratomas were
harvested, sectioned and analyzed for various differentiated cell types and structures.
Accession Numbers. The GEO accession number for the Affymetrix profiling
reported in this paper is GSE28815. The GEO accession numbers for CGH array
reported in this paper are GSM828394, 828395 and 828396.
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